HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions
Patients treated for HPV-related disease are counseled about the potential protective role of HPV vaccination. The investigators will monitor the risk of HPV recurrence in pateints who choce to have vaccination and who did not.
Study Type
OBSERVATIONAL
Enrollment
600
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy
RECRUITINGFondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy
RECRUITINGHPV recurrence
Time frame: 2 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.